New Cannabidivarinic Acid Standard Advances Cannabis Analysis
Jun 18 2020 Read 580 Times
Cannabidivarinic Acid (CBDVA) is a non-psychoactive cannabinoid reported to have anti-inflammatory properties. While its medicinal benefits are still being researched, quantifying this compound in cannabis samples is crucial for obtaining a true measurement of potency and chemovar identification. Restek now offers a new CBDVA certified reference material (CRM) to help labs advance their analysis of cannabis.
Restek’s new CBDVA standard is ideal for creating multipoint (5-point minimum suggested) calibration curves for LC analysis. With verified composition and stability, this prepared stock product eliminates the need for in-house standards preparation for greater convenience and lower labour requirements. As it’s excluded from US DEA Controlled Substances Act (CSA) regulatory controls, no customer permits or licensing required to purchase within the US and because it’s manufactured and QC tested in Restek’s ISO-accredited labs, this new CBDVA standard qualifies as a certified reference material (CRM) that satisfies your ISO requirements.
More information online
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...
View all digital editions
Jan 20 2021 Tokyo, Japan & online
Jan 23 2021 Digital Event
Jan 26 2021 Virtual event
Feb 23 2021 Cologne, Germany
Feb 28 2021 Virtual event